BAILARD, INC. - NAVIDEA BIOPHARMACEUTICALS I ownership

NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 52 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BAILARD, INC. ownership history of NAVIDEA BIOPHARMACEUTICALS I
ValueSharesWeighting
Q1 2019$1,0000.0%10,0000.0%0.00%
Q4 2018$1,000
-50.0%
10,0000.0%0.00%
Q3 2018$2,0000.0%10,0000.0%0.00%
Q2 2018$2,000
-50.0%
10,0000.0%0.00%
Q1 2018$4,0000.0%10,0000.0%0.00%
Q4 2017$4,0000.0%10,0000.0%0.00%
Q3 2017$4,000
-20.0%
10,0000.0%0.00%
Q2 2017$5,000
-16.7%
10,0000.0%0.00%
Q1 2017$6,0000.0%10,0000.0%0.00%
-100.0%
Q4 2016$6,000
-33.3%
10,0000.0%0.00%0.0%
Q3 2016$9,000
+80.0%
10,0000.0%0.00%0.0%
Q2 2016$5,000
-44.4%
10,0000.0%0.00%0.0%
Q1 2016$9,000
-60.9%
10,0000.0%0.00%
-75.0%
Q3 2015$23,000
+43.8%
10,0000.0%0.00%
+100.0%
Q2 2015$16,0000.0%10,0000.0%0.00%0.0%
Q1 2015$16,000
-15.8%
10,0000.0%0.00%
-33.3%
Q4 2014$19,00010,0000.00%
Other shareholders
NAVIDEA BIOPHARMACEUTICALS I shareholders Q2 2017
NameSharesValueWeighting ↓
Sowell Financial Services LLC 506,634$190,0000.05%
Harel Insurance Investments & Financial Services Ltd. 780,000$328,0000.02%
LifePlan Financial Group, Inc 28,810$12,0000.01%
AURORA FINANCIAL ADVISORS, LLC 32,500$11,0000.01%
WEDBUSH SECURITIES INC 169,000$61,0000.01%
Greenwich Wealth Management LLC 60,066$22,0000.00%
Jacobi Capital Management LLC 20,130$8,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 649,880$233,0000.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 436,272$156,0000.00%
McCollum Christoferson Group LLC 17,155$6,0000.00%
View complete list of NAVIDEA BIOPHARMACEUTICALS I shareholders